Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD
Open Access
- 13 October 2020
- journal article
- research article
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 53 (9), 1154-1158
- https://doi.org/10.1016/j.dld.2020.09.021
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse ModelAntioxidants and Redox Signaling, 2013
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver diseaseHepatology, 2013
- Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemiaClinical Biochemistry, 2012
- 8-Oxo-2′-deoxyguanosine as a biomarker of tobacco-smoking-induced oxidative stressFree Radical Biology & Medicine, 2012
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJAMA, 2011
- Interleukin‐10: new perspectives on an old cytokineImmunological Reviews, 2008
- Increased protein carbonyl groups in the serum of patients affected by thalassemia majorAnnals of Hematology, 2006
- Interleukin-6 Depletion Selectively Improves Hepatic Insulin Action in ObesityEndocrinology, 2005
- The anti-inflammatory effect of exerciseJournal of Applied Physiology, 2005
- Mechanisms of interleukin‐10‐mediated immune suppressionImmunology, 2001